Concepedia

Lakshmanan Thiruneelakantapillai

LT

Statistics

Publications

2

Citations

191

H-Index

2

Active since

2009

Affiliations

PTC Therapeutics (United States)(Current)

Lakshmanan Thiruneelakantapillai is an author at PTC Therapeutics (United States) specializing in drug discovery, peptide therapeutics, and medicine.

ORCID

Top concepts

Publications per year

2009–2020

2

Publications

2

Regulation of Insulin Receptor Substrate 1 (IRS-1)/AKT Kinase-mediated Insulin Signaling by O-Linked β-N-Acetylglucosamine in 3T3-L1 Adipocytes

Stephen A. Whelan, Wagner B. Dias, Lakshmanan Thiruneelakantapillai et al. · Journal of Biological Chemistry · 2009 · 172 citations · Full text

Development of peptide therapeutics: A nonclinical safety assessment perspective

Mayur S. Mitra, Steven J. DeMarco, Brad Holub et al. · Regulatory Toxicology and Pharmacology · 2020 · 19 citations

, , +5

1–2 of 2